JP2018504112A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018504112A5 JP2018504112A5 JP2017536271A JP2017536271A JP2018504112A5 JP 2018504112 A5 JP2018504112 A5 JP 2018504112A5 JP 2017536271 A JP2017536271 A JP 2017536271A JP 2017536271 A JP2017536271 A JP 2017536271A JP 2018504112 A5 JP2018504112 A5 JP 2018504112A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polypeptide
- cxcr4
- sequence
- disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001184 polypeptide Polymers 0.000 claims 13
- 102000004196 processed proteins & peptides Human genes 0.000 claims 13
- 108090000765 processed proteins & peptides Proteins 0.000 claims 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 11
- 101710082513 C-X-C chemokine receptor type 4 Proteins 0.000 claims 7
- 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 claims 7
- 201000010099 disease Diseases 0.000 claims 6
- 208000035475 disorder Diseases 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 206010016654 Fibrosis Diseases 0.000 claims 2
- 101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 230000004761 fibrosis Effects 0.000 claims 2
- 208000027866 inflammatory disease Diseases 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 238000006467 substitution reaction Methods 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 1
- 230000008878 coupling Effects 0.000 claims 1
- 238000010168 coupling process Methods 0.000 claims 1
- 238000005859 coupling reaction Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 102000053523 human CXCR4 Human genes 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 239000003053 toxin Substances 0.000 claims 1
- 231100000765 toxin Toxicity 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2015900054 | 2015-01-09 | ||
| AU2015900054A AU2015900054A0 (en) | 2015-01-09 | CXCR4 binding molecules | |
| PCT/AU2016/050005 WO2016109872A1 (en) | 2015-01-09 | 2016-01-08 | Cxcr4 binding molecules |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020121974A Division JP7212009B2 (ja) | 2015-01-09 | 2020-07-16 | Ｃｘｃｒ４結合分子 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018504112A JP2018504112A (ja) | 2018-02-15 |
| JP2018504112A5 true JP2018504112A5 (enExample) | 2019-11-14 |
| JP6863897B2 JP6863897B2 (ja) | 2021-04-21 |
Family
ID=56355354
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017536271A Active JP6863897B2 (ja) | 2015-01-09 | 2016-01-08 | Ｃｘｃｒ４結合分子 |
| JP2020121974A Active JP7212009B2 (ja) | 2015-01-09 | 2020-07-16 | Ｃｘｃｒ４結合分子 |
| JP2022181132A Pending JP2023015277A (ja) | 2015-01-09 | 2022-11-11 | Ｃｘｃｒ４結合分子 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020121974A Active JP7212009B2 (ja) | 2015-01-09 | 2020-07-16 | Ｃｘｃｒ４結合分子 |
| JP2022181132A Pending JP2023015277A (ja) | 2015-01-09 | 2022-11-11 | Ｃｘｃｒ４結合分子 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10538596B2 (enExample) |
| EP (2) | EP3242685B1 (enExample) |
| JP (3) | JP6863897B2 (enExample) |
| CN (2) | CN114478773A (enExample) |
| AU (3) | AU2016206191B2 (enExample) |
| CA (1) | CA2973317A1 (enExample) |
| DK (1) | DK3242685T3 (enExample) |
| ES (1) | ES2924394T3 (enExample) |
| HR (1) | HRP20220860T1 (enExample) |
| LT (1) | LT3242685T (enExample) |
| SG (2) | SG10202111844VA (enExample) |
| WO (1) | WO2016109872A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3242685T3 (da) * | 2015-01-09 | 2022-07-25 | Adalta Ltd | Cxcr4-bindende molekyler |
| TW201803905A (zh) | 2016-06-20 | 2018-02-01 | 克馬伯有限公司 | 用於免疫腫瘤學之多重專一性抗體 |
| US11104725B2 (en) | 2016-11-07 | 2021-08-31 | Degenrx B.V. | Amyloid beta oligomer specific binding molecule |
| EP3568160A1 (en) * | 2017-01-16 | 2019-11-20 | Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V. | Improved multi tyrosine kinase inhibitor therapy |
| TWI818938B (zh) * | 2017-12-19 | 2023-10-21 | 南韓商Ｇｐｃｒ醫療公司 | Gpcr異聚體抑制劑及其用途 |
| JP2022527351A (ja) * | 2019-04-02 | 2022-06-01 | イーライ リリー アンド カンパニー | 結合ペプチドを選択し検出するための方法 |
| JP7676323B2 (ja) * | 2019-05-17 | 2025-05-14 | ジーピーシーアール セラピューティクス，インク． | Ｇｐｃｒヘテロマー阻害剤及びその使用 |
| JP7365674B2 (ja) * | 2019-08-29 | 2023-10-20 | 国立大学法人 長崎大学 | アスペルギローマモデル非ヒト動物 |
| CN110804100A (zh) * | 2019-11-01 | 2020-02-18 | 中国人民解放军陆军特色医学中心 | 融合多肽及其在增强干细胞归巢能力和抗凋亡能力中的应用和药物组合物 |
| EP4118117A1 (en) * | 2020-03-13 | 2023-01-18 | Julius-Maximilians-Universität Würzburg | Affinity matured and humanized binding domains targeting ror2 |
| WO2023092177A1 (en) * | 2021-11-23 | 2023-06-01 | Adalta Limited | Rank-l binding molecules |
| CN114533884A (zh) * | 2022-04-20 | 2022-05-27 | 澳门大学 | 一种联合治疗癌症的药物及s100a9-cxcl12信号抑制剂的应用 |
| WO2025010469A1 (en) * | 2023-07-07 | 2025-01-16 | Adalta Limited | Linking receptor occupancy to efficacy of cxcr4 antagonists |
Family Cites Families (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4475A (en) | 1846-04-25 | Henry johnson | ||
| US196A (en) | 1837-05-15 | Machine for mowing and heaping grain | ||
| US4439A (en) | 1846-04-04 | Improvement in cleansing fish-oils | ||
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| US4447233A (en) | 1981-04-10 | 1984-05-08 | Parker-Hannifin Corporation | Medication infusion pump |
| US4447224A (en) | 1982-09-20 | 1984-05-08 | Infusaid Corporation | Variable flow implantable infusion apparatus |
| US4487603A (en) | 1982-11-26 | 1984-12-11 | Cordis Corporation | Implantable microinfusion pump system |
| US4486194A (en) | 1983-06-08 | 1984-12-04 | James Ferrara | Therapeutic device for administering medicaments through the skin |
| US5206154A (en) | 1985-01-28 | 1993-04-27 | Xoma Corporation | Method of producing cecropins by microbiological techniques |
| US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
| US5215896A (en) | 1987-03-20 | 1993-06-01 | Creative Biomolecules, Inc. | Leader sequences for the production of recombinant proteins |
| US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
| US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
| SE8804074D0 (sv) | 1988-11-10 | 1988-11-10 | Pharmacia Ab | Sensorenhet och dess anvaendning i biosensorsystem |
| ATE102631T1 (de) | 1988-11-11 | 1994-03-15 | Medical Res Council | Klonierung von immunglobulin sequenzen aus den variabelen domaenen. |
| US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
| US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
| US5194594A (en) | 1990-09-07 | 1993-03-16 | Techniclone, Inc. | Modified antibodies |
| EP0564531B1 (en) | 1990-12-03 | 1998-03-25 | Genentech, Inc. | Enrichment method for variant proteins with altered binding properties |
| ZA932522B (en) | 1992-04-10 | 1993-12-20 | Res Dev Foundation | Immunotoxins directed against c-erbB-2(HER/neu) related surface antigens |
| US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
| WO1994004688A2 (en) | 1992-08-21 | 1994-03-03 | The University Of British Columbia | Cationic peptides and method for production |
| US5648244A (en) | 1993-09-27 | 1997-07-15 | President And Fellows Of Harvard College | Production, purification, cleavage and use of fusion peptides |
| US5485277A (en) | 1994-07-26 | 1996-01-16 | Physical Optics Corporation | Surface plasmon resonance sensor and methods for the utilization thereof |
| US6037145A (en) | 1994-09-07 | 2000-03-14 | Suntory Limited | Process for production of protein |
| US5567301A (en) | 1995-03-01 | 1996-10-22 | Illinois Institute Of Technology | Antibody covalently bound film immunobiosensor |
| US5972639A (en) | 1997-07-24 | 1999-10-26 | Irori | Fluorescence-based assays for measuring cell proliferation |
| DE19818790A1 (de) | 1998-04-27 | 1999-10-28 | Affina Immuntechnik Gmbh | Immunadsorptionsmatrix, Verfahren zu ihrer Herstellung und ihre Verwendung |
| AU760048B2 (en) | 1998-05-06 | 2003-05-08 | Genentech Inc. | Protein purification by ion exchange chromatography |
| US6613548B1 (en) | 1998-07-31 | 2003-09-02 | Pierce Biotechnology, Inc. | Fusion products containing insoluble proteinaceous tag |
| US6190908B1 (en) | 1998-08-12 | 2001-02-20 | The Scripps Research Institute | Modulation of polypeptide display on modified filamentous phage |
| US6306610B1 (en) | 1998-09-18 | 2001-10-23 | Massachusetts Institute Of Technology | Biological applications of quantum dots |
| US6242219B1 (en) | 1999-03-18 | 2001-06-05 | Xoma (Us) Llc | Methods for recombinant peptide production |
| JP2003504014A (ja) | 1999-06-30 | 2003-02-04 | エボテック オーアーイー アクチェンゲゼルシャフト | ウイルス状粒子、それらの調製及び好ましくは薬学的スクリーニング及び機能的ゲノムにおけるそれらの使用 |
| US20060228364A1 (en) | 1999-12-24 | 2006-10-12 | Genentech, Inc. | Serum albumin binding peptides for tumor targeting |
| US20050287153A1 (en) | 2002-06-28 | 2005-12-29 | Genentech, Inc. | Serum albumin binding peptides for tumor targeting |
| CA2406873A1 (en) | 2000-04-25 | 2001-11-01 | Chemicon International, Inc. | Cell proliferation assay |
| WO2002026292A1 (de) | 2000-09-28 | 2002-04-04 | Affina Immuntechnik Gmbh | Durchflussvorrichtung zum trennen von substanzen in körperflüssigkeiten, insbesondere blut und dessen verwendung |
| ES2343061T3 (es) | 2002-05-24 | 2010-07-22 | Medtronic, Inc. | Metodos y constructos de dna para produccion de polipeptidos con rendimiento alto. |
| US8574590B2 (en) | 2003-07-30 | 2013-11-05 | Integral Molecular, Inc. | Lipoparticles comprising proteins, methods of making, and using the same |
| WO2005108415A2 (en) * | 2004-04-30 | 2005-11-17 | Biogen Idec Ma Inc. | Membrane associated molecules |
| CA2569240A1 (en) | 2004-06-01 | 2005-12-15 | Domantis Limited | Drug fusion comprising a polypeptide drug and an immunoglobulin heavy chain variable domain specific for serum albumin |
| EP2330120A3 (en) * | 2004-06-02 | 2011-11-16 | AdAlta Pty Ltd | Binding moieties based on Shark IgNAR domains |
| US7671069B2 (en) | 2006-03-30 | 2010-03-02 | Chemocentryx, Inc. | Tricyclic, heteroaromatic compounds modulating CXCR4 and/ or CXCR7 |
| US7807704B2 (en) | 2006-03-30 | 2010-10-05 | Chemocentryx, Inc. | Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 |
| AU2007320024B2 (en) * | 2006-10-02 | 2012-11-08 | E. R. Squibb & Sons, L.L.C. | Human antibodies that bind CXCR4 and uses thereof |
| US8088895B2 (en) | 2006-10-18 | 2012-01-03 | Chemocentryx, Inc. | Antibodies that bind CXCR7 epitopes |
| US8283127B2 (en) | 2006-11-10 | 2012-10-09 | Dimerix Bioscience Pty Ltd. | Detection system and uses therefor |
| US20080261978A1 (en) | 2007-03-08 | 2008-10-23 | Clark Michael P | Chemokine receptor modulators |
| EA201001529A1 (ru) * | 2008-03-20 | 2011-06-30 | Каролус Терапьютикс, Инк. | Способ и композиция для лечения mif-опосредованных расстройств |
| WO2010033913A1 (en) * | 2008-09-22 | 2010-03-25 | Icb International, Inc. | Antibodies, analogs and uses thereof |
| US20100136584A1 (en) * | 2008-09-22 | 2010-06-03 | Icb International, Inc. | Methods for using antibodies and analogs thereof |
| MX2011004490A (es) | 2008-11-04 | 2011-07-20 | Chemocentryx Inc | Moduladores de cxcr7. |
| WO2011083140A1 (en) | 2010-01-08 | 2011-07-14 | Ablynx Nv | Immunoglobulin single variable domain directed against human cxcr4 |
| EA026153B1 (ru) * | 2011-11-09 | 2017-03-31 | Бристол-Майерс Сквибб Компани | Лечение гематологических злокачественных заболеваний с помощью анти-cxcr4 антитела |
| EP2964332A4 (en) * | 2013-03-08 | 2016-09-14 | Curonz Holdings Company Ltd | NEURAL REGENERATION PEPTIDES AND USES THEREOF |
| DK3242685T3 (da) * | 2015-01-09 | 2022-07-25 | Adalta Ltd | Cxcr4-bindende molekyler |
-
2016
- 2016-01-08 DK DK16734863.0T patent/DK3242685T3/da active
- 2016-01-08 CA CA2973317A patent/CA2973317A1/en active Pending
- 2016-01-08 US US15/542,060 patent/US10538596B2/en active Active
- 2016-01-08 SG SG10202111844VA patent/SG10202111844VA/en unknown
- 2016-01-08 CN CN202210051480.9A patent/CN114478773A/zh not_active Withdrawn
- 2016-01-08 CN CN201680010938.9A patent/CN107427574B/zh active Active
- 2016-01-08 LT LTEPPCT/AU2016/050005T patent/LT3242685T/lt unknown
- 2016-01-08 HR HRP20220860TT patent/HRP20220860T1/hr unknown
- 2016-01-08 EP EP16734863.0A patent/EP3242685B1/en active Active
- 2016-01-08 EP EP22171019.7A patent/EP4112077A1/en active Pending
- 2016-01-08 AU AU2016206191A patent/AU2016206191B2/en active Active
- 2016-01-08 WO PCT/AU2016/050005 patent/WO2016109872A1/en not_active Ceased
- 2016-01-08 ES ES16734863T patent/ES2924394T3/es active Active
- 2016-01-08 SG SG11201705583XA patent/SG11201705583XA/en unknown
- 2016-01-08 JP JP2017536271A patent/JP6863897B2/ja active Active
-
2017
- 2017-10-31 AU AU2017254863A patent/AU2017254863A1/en not_active Abandoned
-
2019
- 2019-05-20 AU AU2019203511A patent/AU2019203511B2/en active Active
- 2019-12-18 US US16/719,125 patent/US11142588B2/en active Active
-
2020
- 2020-07-16 JP JP2020121974A patent/JP7212009B2/ja active Active
-
2022
- 2022-11-11 JP JP2022181132A patent/JP2023015277A/ja active Pending